Fetal surgery for spina bifida: understanding in utero repair outcomes

Spina bifida is a neural tube defect in which the developing spinal cord and surrounding tissues do not form normally. The most severe form, myelomeningocele, can lead to lower-limb weakness, bladder and bowel dysfunction, hydrocephalus, and Chiari II malformation. Traditionally, repair took place after birth, but fetal surgery has introduced an earlier approach: closing the spinal lesion before delivery to reduce ongoing damage during pregnancy.

In utero repair does not reverse every effect of the condition, and it is not suitable for every pregnancy. Instead, it aims to change the course of disease by protecting exposed neural tissue from prolonged contact with amniotic fluid and mechanical trauma. The decision involves detailed imaging, genetic and maternal assessment, multidisciplinary counseling, and careful consideration of maternal and fetal risks.

Research presented and discussed in perinatal medicine continues to shape how clinicians interpret these results. The FAOPS 2020 congress archive reflects the broader scientific setting in which fetal medicine, neonatal care, and pregnancy research are evaluated together rather than as isolated specialties.

Why timing matters in myelomeningocele

During fetal development, an open spinal lesion leaves delicate neural tissue exposed. The lesion may become progressively damaged as pregnancy advances, which helps explain why a child’s neurological function can be affected before birth. The level and size of the defect, associated brain findings, and the degree of lower-limb movement seen on ultrasound all influence the expected outcome.

Prenatal closure is intended to interrupt this process. By covering the spinal defect during gestation, surgeons aim to reduce further injury and limit the abnormal flow of cerebrospinal fluid that contributes to hindbrain herniation. The treatment therefore has two connected goals: preserve neurological function where possible and reduce the need for treatment of hydrocephalus after delivery.

This biological rationale does not mean that fetal surgery produces normal development. Existing damage cannot necessarily be repaired, and outcomes vary considerably. A fetus with a high-level lesion and limited movement may face a different prognosis from one with a lower lesion and preserved motor activity, even when both receive technically successful closure.

What the major evidence shows

The landmark Management of Myelomeningocele Study compared prenatal open repair with standard postnatal surgery in carefully selected pregnancies. The study found that prenatal surgery reduced the need for cerebrospinal fluid shunt placement at 12 months and improved the degree of hindbrain herniation at one year. At 30 months, children who underwent fetal repair also showed better composite scores for mental development, motor development, and functional mobility.

These findings established fetal surgery as a clinically meaningful option rather than an experimental concept without measurable benefit. The results are especially important because shunt dependence can bring repeated procedures and long-term complications. Still, the trial did not show that every child would walk independently or avoid bladder, bowel, orthopedic, or developmental problems.

Subsequent follow-up and clinical experience have reinforced the value of early closure while emphasizing the complexity of long-term care. Neurological level, ventricular size, tethered cord, orthopedic alignment, renal function, and access to rehabilitation all affect a child’s life. Fetal intervention changes probabilities; it does not remove the need for pediatric neurosurgery, urology, orthopedics, physiotherapy, and developmental surveillance.

Comparing repair approaches and outcomes

The surgical method influences both potential benefit and risk. Open fetal surgery involves a maternal abdominal incision and temporary opening of the uterus, followed by direct repair of the fetal back. Fetoscopic techniques use smaller access points and specialized instruments, but approaches differ between centers and may have different technical demands, learning curves, and delivery implications.

Evidence should be interpreted according to the procedure offered, the experience of the center, and the eligibility criteria used. A result from a highly specialized program may not translate directly to a hospital with limited fetal therapy infrastructure. Families need outcome data that distinguish survival, neurological function, shunt placement, preterm birth, maternal complications, and later quality of life.

Eligibility, evaluation, and maternal risk

Candidates are generally assessed against strict criteria based on fetal diagnosis, gestational age, lesion level, ventricular measurements, genetic findings, and maternal health. High-resolution ultrasound and fetal MRI help define the spinal defect and brain anatomy. Clinicians also assess whether the pregnancy has other abnormalities that could change the expected benefit or make surgery unsafe.

Maternal consent must be genuinely informed because the operation is performed for fetal benefit while exposing the pregnant patient to substantial risks. These can include uterine incision complications, bleeding, infection, pulmonary problems, placental abnormalities, preterm premature rupture of membranes, and preterm birth. A uterine scar may also affect delivery planning and future pregnancies, including the risk of placenta accreta spectrum.

Emotional and practical factors deserve equal attention. The family may need to travel to a specialist center, remain near the hospital for weeks, and plan for neonatal intensive care. Guidance on managing high-risk pregnancies also illustrates why continuity, communication, and coordinated care matter when ordinary prenatal pathways are disrupted.

Care after fetal closure

Prenatal repair does not end the pregnancy’s medical monitoring. Serial ultrasound is used to assess ventricular size, amniotic fluid, membrane integrity, fetal growth, and signs of preterm labor. The surgical site is observed for evidence of dehiscence or other complications. Delivery is planned around the condition of the mother and fetus, the type of repair, and the protocol of the treating center.

After birth, the newborn is examined for motor function, wound integrity, hydrocephalus, respiratory stability, and bladder function. Some infants need ventricular treatment, while others can be monitored with imaging and clinical assessments. Neonatal specialists also watch for complications associated with prematurity, which may influence early feeding, breathing, and neurodevelopment.

Long-term follow-up is essential for interpreting true treatment success. A child may have fewer neurosurgical procedures yet still require catheterization, bowel management, orthoses, mobility aids, or educational support. Outcomes should therefore be measured in terms of independence, participation, comfort, continence, mobility, cognitive development, and family well-being—not solely by whether a shunt was placed.

Building a responsible counseling process

Families benefit when counseling separates established evidence from uncertain outcomes. Clinicians should explain what prenatal repair has demonstrated, what remains variable, and which results depend on lesion level, fetal movement, gestational age at treatment, surgical technique, and postnatal services. Numerical estimates can be useful, but they should be presented as population-level findings rather than a personal prediction.

A balanced consultation should address:

• The expected neurological effects of the fetal lesion before treatment
• The possible reduction in shunt placement and hindbrain herniation
• Maternal surgical risks and implications for future pregnancies
• The likelihood of membrane rupture, preterm delivery, and neonatal intensive care
• The child’s probable need for lifelong neurological, urological, orthopedic, and developmental follow-up

Shared decision-making is particularly important because there is no risk-free option. Choosing prenatal repair means accepting maternal and obstetric risks in pursuit of improved fetal outcomes. Choosing postnatal repair avoids fetal surgery but permits the lesion to remain exposed until birth. Neither path should be described as a guaranteed solution or a failure of parental commitment.

Advancing care through research and follow-up

The next stage of fetal therapy research involves refining patient selection, improving minimally invasive techniques, and identifying which children gain the greatest functional advantage. Researchers are also examining prenatal biomarkers, fetal movement patterns, ventricular progression, rehabilitation strategies, and methods for reducing preterm birth. Comparative studies need long follow-up because early neurological findings do not capture the full effect on childhood development.

Multidisciplinary registries can improve the quality of evidence by recording maternal health, surgical details, gestational age at delivery, neonatal complications, and outcomes over many years. Consistent definitions are especially valuable when comparing open fetal repair, fetoscopic closure, and postnatal surgery across institutions.

Fetal surgery for spina bifida represents a significant shift in perinatal medicine: treatment begins before birth, but success depends on care that continues throughout childhood. Families considering this option should seek evaluation from an experienced fetal therapy program and review individualized risks, likely benefits, alternatives, and long-term support before making a decision.